Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.03M Buy
22,182
+1,023
+5% +$350K 0.17% 73
2026
Q1
$7.44M Sell
21,159
-9,833
-32% -$3.51M 0.16% 67
2025
Q4
$10.1M Buy
30,992
+10,041
+48% +$3.19M 0.22% 60
2025
Q3
$5.91M Buy
20,951
+247
+1% +$71.6K 0.14% 94
2025
Q2
$5.79M Buy
20,704
+191
+0.9% +$54.1K 0.15% 86
2025
Q1
$6.39M Sell
20,513
-12
-0.1% -$3.54K 0.17% 66
2024
Q4
$5.36M Sell
20,525
-40
-0.2% -$11.9K 0.13% 92
2024
Q3
$6.63M Sell
20,565
-15,372
-43% -$5.03M 0.16% 81
2024
Q2
$11.2M Sell
35,937
-9,061
-20% -$2.66M 0.3% 41
2024
Q1
$12.8M Buy
44,998
+9,387
+26% +$2.75M 0.36% 35
2023
Q4
$10.3M Buy
+35,611
New +$9.7M 0.31% 45

Other funds holding AMGN

AlTi Global's AMGN Position: Q2 2026 in Review

AlTi Global increased its Amgen (AMGN) stake by 4.8% in Q2 2026, buying an estimated $350K and bringing the position to 22,182 shares worth $8.03M. The position accounts for 0.17% of the portfolio, ranked #73.

AlTi Global first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $12.8M in Q1 2024. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • AlTi Global held 22,182 shares of Amgen worth $8.03M as of Q2 2026.
  • AlTi Global bought 1,023 Amgen shares in Q2 2026, an estimated $350K.
  • Amgen made up 0.17% of AlTi Global's portfolio in Q2 2026, its #73 holding.
  • AlTi Global first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • AlTi Global's Amgen position peaked at $12.8M in Q1 2024.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on AlTi Global's 13F filing for Q2 2026, filed 5 Aug 2026.